Objective. The main objective was to determine the 2-year clinical benefit and safety of
etanercept (ETN) in children with the juvenile idiopathic arthritis (JIA) categories of extended …

Background Little is known about the disposition to autoimmune diseases (ADs) among
children diagnosed with JIA. In this study, we provide a comprehensive overview of the …

Objectives To retrospectively evaluate clinical efficacy, from perspective of growth velocity as
a sensitive marker of well-being in children, of biologics in children with JIA in both centers …

There in an increasing prevalence of hip arthroplasty procedures for hip fractures in patients
over the age of 80. We describe the oldest living patient to undergo such an intervention. …

To the Editor: Juvenile idiopathic arthritis (JIA) is a heterogeneous group of arthritides of
unknown cause, which begins before the age of 16 years and lasts for at least 6 weeks. With a …

Objectives To describe a cohort of CRMO patients and to characterize treatment effects with
focus on bisphosphonates in a retrospective study of a case series. Methods Between 1995 …

The authors of this chapter discuss the atypical course of Still’s disease in adulthood. It is a
sine syndrome (skin changes, itchy, linear urticarial rash or other skin manifestations, …

Sine syndromes (SSs) represent a problem in clinical medicine, especially if the diagnosis
is not determined by pathognomic findings, eg, identification of microbial pathogens, sodium-…

Objective To investigate the efficacy and safety of etanercept (ETN) in paediatric subjects
with extended oligoarticular juvenile idiopathic arthritis (eoJIA), enthesitis-related arthritis (ERA)…